Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn's Disease.
Journal
Crohn's & colitis 360
ISSN: 2631-827X
Titre abrégé: Crohns Colitis 360
Pays: England
ID NLM: 101752188
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
02
04
2020
entrez:
13
2
2023
pubmed:
3
6
2020
medline:
3
6
2020
Statut:
epublish
Résumé
Crohn's disease (CD) can be classified according to endoscopic and cross-sectional imaging characteristics. Information regarding disease extent and phenotype may be provided by advanced endoscopic and imaging techniques. In this study, we compare the ability of capsule endoscopy (CE) and cross-sectional imaging techniques (CST) (MRE/Computer Tomography Enteroscopy [CTE]) in detecting small bowel (SB) lesions. We retrospectively analyzed 102 patients with a diagnosis of CD who underwent both CE and CST. Only patients with at least a 12-month follow-up after CE were included. Sensitivity and specificity for the detection of SB lesions were, respectively, 100% and 83.3% for CE, 55.1% and 80% for CTE, and 60% and 82.3% for MRE. CE detected proximal CD lesions in 73% of patients, whereas MRE and CTE detected proximal lesions in 41% and 16% of patients, respectively ( CE has a superior sensitivity for detecting CD lesions in the proximal and medium SB compared with CST. In the terminal ileum, MRE and CTE displayed similar performance to CE.
Sections du résumé
Background
UNASSIGNED
Crohn's disease (CD) can be classified according to endoscopic and cross-sectional imaging characteristics. Information regarding disease extent and phenotype may be provided by advanced endoscopic and imaging techniques. In this study, we compare the ability of capsule endoscopy (CE) and cross-sectional imaging techniques (CST) (MRE/Computer Tomography Enteroscopy [CTE]) in detecting small bowel (SB) lesions.
Methods
UNASSIGNED
We retrospectively analyzed 102 patients with a diagnosis of CD who underwent both CE and CST. Only patients with at least a 12-month follow-up after CE were included.
Results
UNASSIGNED
Sensitivity and specificity for the detection of SB lesions were, respectively, 100% and 83.3% for CE, 55.1% and 80% for CTE, and 60% and 82.3% for MRE. CE detected proximal CD lesions in 73% of patients, whereas MRE and CTE detected proximal lesions in 41% and 16% of patients, respectively (
Conclusions
UNASSIGNED
CE has a superior sensitivity for detecting CD lesions in the proximal and medium SB compared with CST. In the terminal ileum, MRE and CTE displayed similar performance to CE.
Identifiants
pubmed: 36777299
doi: 10.1093/crocol/otaa046
pii: otaa046
pmc: PMC9802189
doi:
Types de publication
Journal Article
Langues
eng
Pagination
otaa046Informations de copyright
© 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation.
Références
Am J Gastroenterol. 2006 May;101(5):965-6
pubmed: 16696782
Inflamm Bowel Dis. 2018 Mar 19;24(4):775-780
pubmed: 29506048
Inflamm Bowel Dis. 2018 Jun 8;24(7):1582-1588
pubmed: 29788055
Radiology. 2009 Jun;251(3):751-61
pubmed: 19276325
Gut Liver. 2017 Jan 15;11(1):62-72
pubmed: 27728963
Inflamm Bowel Dis. 2013 Jun;19(7):1390-6
pubmed: 23552764
Gut. 2003 Mar;52(3):390-2
pubmed: 12584221
World J Gastrointest Endosc. 2011 Feb 16;3(2):23-9
pubmed: 21403813
Science. 1988 Jun 3;240(4857):1285-93
pubmed: 3287615
World J Gastroenterol. 2019 Aug 21;25(31):4534-4554
pubmed: 31496630
Gastroenterology. 2011 May;140(6):1785-94
pubmed: 21530745
Am J Gastroenterol. 2009 Feb;104(2):371-83
pubmed: 19174787
J Crohns Colitis. 2016 May;10(5):525-31
pubmed: 26748404
Endoscopy. 2005 Oct;37(10):1065-7
pubmed: 16189792
Gastroenterol Clin North Am. 2012 Jun;41(2):315-23
pubmed: 22500520
J Crohns Colitis. 2017 Jan;11(1):3-25
pubmed: 27660341
Am J Gastroenterol. 2013 Jan;108(1):106-12
pubmed: 23229423
Gastrointest Endosc. 2018 Dec;88(6):947-955.e2
pubmed: 30086261
Am J Gastroenterol. 2015 Sep;110(9):1324-38
pubmed: 26303131
World J Gastroenterol. 2004 May 1;10(9):1349-52
pubmed: 15112357
Aliment Pharmacol Ther. 2011 Jul;34(2):125-45
pubmed: 21615440
World J Gastroenterol. 2010 Jul 14;16(26):3299-304
pubmed: 20614486
J Crohns Colitis. 2015 Dec;9(12):1146-51
pubmed: 26377028
Am J Gastroenterol. 2008 Dec;103(12):3082-93
pubmed: 19086959
Endoscopy. 2003 Jul;35(7):564-8
pubmed: 12822090
Can J Gastroenterol. 2005 Sep;19 Suppl A:5A-36A
pubmed: 16151544
Gut. 2006 Aug;55(8):1124-30
pubmed: 16361306
Gastroenterology. 2006 Mar;130(3):650-6
pubmed: 16530505
Am J Gastroenterol. 2006 May;101(5):954-64
pubmed: 16696781
Inflamm Bowel Dis. 2011 Sep;17(9):1855-62
pubmed: 21830264
Inflamm Bowel Dis. 2015 Jan;21(1):93-100
pubmed: 25517597
J Crohns Colitis. 2014 Dec;8(12):1610-5
pubmed: 24631311
Am J Gastroenterol. 2010 Jun;105(6):1240-8; quiz 1249
pubmed: 20029412
J Crohns Colitis. 2013 Dec;7(12):982-1018
pubmed: 24184171